HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health (OTC Drugs)

Set Alert for Health (OTC Drugs)

Regulation/Legislation Explore this Topic

Set Alert for Regulation and Legislation {Health}

Latest From Regulation, Legislation & Health

AESGP Conference Round-Up: Digital Disruption, Med Device Worries And The Benefits Of Switching

Speakers from the EMA and European Commission, as well as Pfizer and HRA Pharma, debated at the AESGP's Regulatory Conference the ongoing digital transformation of the European consumer healthcare market, the latest developments in the implementation of the new medical devices regulations, and the best ways to encourage Rx-to-OTC switching across the EU.
Europe Health

Industry Groups To Request FDA Rulemaking Deferrals For Sunscreen Ingredients In Question

Trade groups PCPC and CHPA say they likely will request that FDA defer further rulemaking on sunscreen ingredients that require additional data to retain their GRASE designations under the agency’s proposed rule for a final OTC sunscreen drug monograph, issued in February. For now, the associations are asking for an extension of the allotted comment period beyond May 28, 2019.

FDA Regulation

OTCs Under Threat In Europe: Calls To Reverse-Switch Codeine And Others In Poland And Ireland

Poland's ministry of health is calling for codeine, dextromethorphan and pseudoephedrine to be reverse-switched from OTC to prescription status in response to abuse of the drugs by adolescents. At the same time, an academic paper argues Ireland should restrict codeine to prescription-only sale to combat an addiction epidemic "verging on eruption."
Prescription To Otc Switch Poland

AESGP Supports European Commission On Environment

European self-medication association AESGP is one of several European pharmaceutical industry bodies to have lent their backing to the latest European Commission strategic approach to pharmaceuticals in the environment.
Europe Regulation

Abortion Pills Offered Nonprescription By E-Commerce Firms FDA Warned

One active ingredient in unapproved drugs sold by two e-commerce operations, identified by FDA as Rabold and AidAccess.org, is mifepristone, also known as RU-486 in the only drug with the ingredient approved for an indication of medical termination of early pregnancy, Danco Laboratories' Mifeprex. Firms' websites offer sales of products without requiring customers to submit prescriptions.

Regulation E-Commerce

France’s Prime Minister Wades Into Liberalisation Debate, Claiming Online Restrictions Have Gone “Too Far”

France's Prime Minister Edouard Philippe intervenes in the debate over whether to liberalize the country's still very traditional pharmacy market. 

Health OTC Drugs
See All

Business Explore this Topic

Set Alert for Business {Health}

Latest From Deals & Health

Zentiva Set To Acquire Romania's Solacium

Zentiva has signed its first acquisition after it was carved out from Sanofi last year to become an independent company, entering into a shared purchase agreement with Siyiara to acquire Romania-based food supplement and OTC medicines producer Solacium.
Deals Romania

Probe Into GSK/Pfizer Consumer Tie-up Launched By Australian Competition Watchdog

Assessing how closely GSK's brands such as Panadol compete with Pfizer brands like Robitussin is the aim of an investigation launched by Australia's Competition and Consumer Commission into the pharma giants' proposed consumer health joint venture. 
Deals Regulation

Teva Licenses OTC And Cosmetics Portfolio To Trimb In Scandinavia

Trimb has gained the exclusive rights from Teva to market across Scandinavia a portfolio of "well-known" consumer health brands, covering skin-care, oral-care, and digestive health, as well as dietary supplements. 
Deals Sweden
See All

Latest From Business Strategies & Health

Providing High Value, OTC Drugs Deserve Higher Profile In Health Care – CHPA

While Rx drug pricing is under attack by Congress, White House and consumer and public health advocacy groups, OTC drugs' value isn't gaining a higher profile. "Our health care system undervalues the contribution of our industry's products," says CHPA chief Scott Melville. Trade group conducts “Value of OTC Medicines" study for reasons including raising the profile of consumer health products in the US health care system.

Health Wellness

Zur Rose Steams Ahead With Acquisition-Led Expansion Amid Investor Concerns

Zur Rose adds French online retail platform Doctipharma as two board members resign over “differences of opinion” with regards to the firm's growth strategy.

Health Business Strategies

SPF Testing Costs (And Variability) Could Be Reduced With In Vitro Method Uptake

Cosmetics Europe expects its in vitro method for SPF determination to be a published ISO standard within two to three years. The European Commission is behind in vitro sunscreen testing, and the method could significantly reduce costs and technical challenges while providing in vivo-equivalent results, the trade group says.

Beauty Standards
See All

Latest From Sales & Earnings & Health

Bayer Bullish On Consumer Health’s Prospects Despite ‘Challenging’ 2018

Notwithstanding a particularly difficult 2018, Bayer Consumer Health still has "one of the best brand portfolios," and can continue to compete with the market leaders, says CEO Werner Baumann. Consumer Health struggled particularly in the US and Europe in the 12 months, with the majority of its leading brands recording poor performances.
Sales & Earnings Business Strategies

Reckitt ‘Not Happy’ With Consumer Health Growth In 2018, Following European And Infant Nutrition Woes

RB's Health business failed to keep pace with market growth in 2018, with the firm admitting its mindset in Europe "needs to change." The UK-based consumer-goods giant spent the 12 months working on its RB 2.0 restructuring program, which will give it the option to separate into two independent companies focusing on Health and Hygiene by 2020.
Sales & Earnings Business Strategies

France's OTC Market in 2018: Self-Medication Sales Slump, Sanofi Claims Number-One Spot

France's self-medication market had a difficult 2018, due to a weak flu season and changing dynamics in the sector, according to industry association Afipa. Despite this it was a good year for Sanofi, which overtook Boiron as the number-one OTC firm in the market, while its Doliprane analgesic became France's best-selling brand.
France Market Intelligence
See All

Latest From Legal Issues & Health

Perrigo Lights Smoking Cessation For Growth With Turnaround Woes 'Fixable'

As "market leader" in OTC nicotine replacement treatments, Perrigo should "be the one that's doing a lot of innovation," says CEO Murray Kessler. He discussed Perrigo's problems and potential sales drivers as it reported 2018 net sales of $4.7bn, down 4% , and Q4 net sales of $1.2bn, down 7%. Global consumer health product sales for year were flat at $3.9bn and Q4 sales were down 4% at $973m.

International Europe

Biotene OTC Dry Mouth Competitor Remains On Market As GSK Litigates

Former Biotene owner Laclede ordered by federal judge to stop using brand, now owned by GSK, to promote its competing line of Salivea dry mouth products. But judge rejected GSK’s request that the Salivea dry mouth product marketers are subject to a lifetime non-compete agreement.

Commercial OTC Drugs

J&J CEO Sees Victory Ahead On Talc, Growth From Johnson's Relaunch

JP Morgan analysts had questions and J&J CEO Alex Gorsky and CFO Joseph Wolk had answers about liability suits alleging that use of the Johnson's brand talcum powder has caused mesothelioma or ovarian cancer. On the Johnson's brand outlook following its relaunch as a natural product line, Gorsky says sales were a key driver in the firm's consumer health sales in the 2018 third quarter. China, meanwhile, is a model for growing sales online, he says.
Legal Issues Ingredients
See All

Marketing Explore this Topic

Set Alert for Marketing {Health}

Latest From Launches & Health

OTC Marketing Awards 2019 Winners Announced – GSK Crowned Company Of The Year, Pfizer’s Viagra Takes Best Brand

GSK, Pfizer, HRA Pharma and Mentholatum all enjoyed a particularly fruitful evening at the OTC Marketing Awards 2019. J&J, P&G and RB were also among the winners at a celebration of the best and brightest in the UK consumer health market. 
Ad Campaigns Launches

Sanofi Overcomes Series Of Challenges To Return Syndol OTC Migraine Treatment To UK After 5-Year Absence

Sanofi has overcome production challenges to bring its OTC migraine and tension headache treatment Syndol back to the UK market after more than five years away.
United Kingdom Health

Health And Wellness Weekly Trademark Review Feb. 26, 2019

Trademarks registered and published for opposition with UDPTO in Class 3 – cosmetics and cleaning Preps, and Class 5 –pharmaceuticals. Marks for vitamin, mineral and supplement products also are registered or published for opposition in both Class 3 and Class 5.

Dietary Supplements OTC Drugs
See All

Latest From Ad Campaigns & Health

OTC Marketing Awards 2019 Winners Announced – GSK Crowned Company Of The Year, Pfizer’s Viagra Takes Best Brand

GSK, Pfizer, HRA Pharma and Mentholatum all enjoyed a particularly fruitful evening at the OTC Marketing Awards 2019. J&J, P&G and RB were also among the winners at a celebration of the best and brightest in the UK consumer health market. 
Ad Campaigns Launches

Sanofi Clarifies Xyzal-Zyrtec Size Comparison, Outweighs J&J Calculation

National Advertising Division recommends Sanofi add "nearly" to claim that Xyzal Allergy 24HR is "as effective at half the size" of J&J's Zyrtec in a TV ad because 3D modeling comparing the products showed Xyzal tablet has 73-mm volume and a Zyrtec tablet's is 145.2 mm. Sanofi's evidence also supported referring to Xyzal's size would not mislead consumers to expect its drug has half the pharmaceutical dosage of Zyrtec.

France Germany

P&G Olay Play Could Shift Women's Products Advertising During Super Bowl

Olay skin care ad during Super Bowl with actress Sarah Michelle Geller could usher in era of for women’s products during the event. Marketing experts say as advertisers look to identify more with women’s issues and take on political or social bents, they should tie brands with messaging that is straightforward.

Beauty Health
See All

Latest From Ad Complaints & Health

Ouch! Two UK Analgesic Ad Complaints: Reckitt Rapped, Perrigo Pardoned

Two UK advertising complaint verdicts delivered by the MHRA, Reckitt Benckiser's Nurofen Express (upheld) and Perrigo's Solpadeine Max (not upheld).

Health OTC Drugs

ASA Clears RB Of Misleading UK Consumers In Two Nurofen Ads

The UK's Advertising Standards Authority has cleared Reckitt Benckiser of misleading British consumers with two advertisements for its Nurofen brand of analgesics.
Health OTC Drugs

Oral-B Enamel Repair Claim Has Second Brush With UK Advertising Authority

UK Advertising Standards Authority says despite P&G’s modification of a claim in TV ads for Oral B Gum and Enamel Repair toothpaste, visuals in the ad combined with claims suggest the product can repair enamel.

Regulation Commercial
See All
UsernamePublicRestriction

Register